{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:13:38Z","timestamp":1790993618106,"version":"4.1.0"},"reference-count":55,"publisher":"FapUNIFESP (SciELO)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An. Bras. Dermatol."],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1590\/abd1806-4841.20142717","type":"journal-article","created":{"date-parts":[[2014,8,30]],"date-time":"2014-08-30T19:31:58Z","timestamp":1409427118000},"page":"784-790","source":"Crossref","is-referenced-by-count":69,"title":["Vitiligo - Part 2 - classification, histopathology and treatment"],"prefix":"10.1590","volume":"89","author":[{"given":"Adriane Reichert","family":"Faria","sequence":"first","affiliation":[{"name":"Santa Casa de Miseric\u00f3rdia Hospital, Brazil; Pontif\u00edcia Universidade Cat\u00f3lica do Paran\u00e1, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto Gomes","family":"Tarl\u00e9","sequence":"additional","affiliation":[{"name":"Santa Casa de Miseric\u00f3rdia Hospital, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerson","family":"Dellatorre","sequence":"additional","affiliation":[{"name":"Santa Casa de Miseric\u00f3rdia Hospital, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo T\u00e1vora","family":"Mira","sequence":"additional","affiliation":[{"name":"Pontif\u00edcia Universidade Cat\u00f3lica do Paran\u00e1, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caio Cesar Silva de","family":"Castro","sequence":"additional","affiliation":[{"name":"Santa Casa de Miseric\u00f3rdia Hospital, Brazil; Pontif\u00edcia Universidade Cat\u00f3lica do Paran\u00e1, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1755-148X.2012.00997.x","article-title":"Revised classification\/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference","volume":"25","author":"Ezzedine K","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jdermsci.2011.09.011","article-title":"A pattern of association between clinical form of vitiligo and disease-related variables in a Brazilian population","volume":"65","author":"Silva de Castro CC","year":"2012","journal-title":"J Dermatol Sci"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nature05660","article-title":"Melanocyte biology and skin pigmentation","volume":"445","author":"Lin JY","year":"2007","journal-title":"Nature"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1600-0749.2006.00313.x","article-title":"The discovery of the human melanocyte","volume":"19","author":"Westerhof W","year":"2006","journal-title":"Pigment Cell Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.0022-202X.2005.23667.x","article-title":"Less keratinocyte-derived factors related to more keratinocyte apoptosis in depigmented than normally pigmented suctionblistered epidermis may cause passive melanocyte death in vitiligo","volume":"124","author":"Lee AY","year":"2005","journal-title":"J Invest Dermatol"},{"key":"ref6","series-title":"Dermatology in general medicine","author":"Fitzpatrick TB","year":"1993","edition":"4th ed"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1087-0024.2005.200407.x","article-title":"Normal human melanocyte homeostasis as a paradigm for understanding melanoma","volume":"10","author":"Haass NK","year":"2005","journal-title":"J Investig Dermatol Symp Proc"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.det.2007.06.005","article-title":"Melanocyte receptors: clinical implications and therapeutic relevance","volume":"25","author":"Carlson JA","year":"2007","journal-title":"Dermatol Clin"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1034\/j.1600-0749.2002.1o049.x","article-title":"New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions","volume":"15","author":"Moretti S","year":"2002","journal-title":"Pigment Cell Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0738-081X(97)00127-2","article-title":"Microscopic changes in vitiligo","volume":"15","author":"Le Poole IC","year":"1997","journal-title":"Clin Dermatol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/1523-1747.ep12476645","article-title":"Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation","volume":"100","author":"Le Poole IC","year":"1993","journal-title":"J Invest Dermatol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH659>3.0.CO;2-D","article-title":"Melanocytes are not absent in lesional skin of long duration vitiligo","volume":"191","author":"Tobin DJ","year":"2000","journal-title":"J Pathol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1346-8138.2010.01139.x","article-title":"Vitiligo: a review of the published work","volume":"38","author":"Yaghoobi R","year":"2011","journal-title":"J Dermatol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/DAD.0b013e3181651511","article-title":"Histopathologic features in vitiligo","volume":"30","author":"Kim YC","year":"2008","journal-title":"Am J Dermatopathol"},{"key":"ref15","first-page":"81","article-title":"Clinical image: an unusual pigmented basal cell carcinoma arising from vulva","volume":"20","author":"Yaghoobi R","year":"2011","journal-title":"Acta Dermatovenerol Alp Panonica Adriat"},{"key":"ref16","first-page":"473","article-title":"Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up","volume":"65","author":"Alikhan A","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/0378-6323.90943","article-title":"On the pathophysiology of vitiligo: possible treatment options","volume":"78","author":"Boissy RE","year":"2012","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/jid.2009.32","article-title":"Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients","volume":"129","author":"van den Boorn JG","year":"2009","journal-title":"J Invest Dermatol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/01.LAB.0000069521.42488.1B","article-title":"Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo","volume":"83","author":"Wa?kowicz-Kali?ska A","year":"2003","journal-title":"Lab Invest"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/1523-1747.ep12500086","article-title":"Extracellular granular material and degeneration of keratinocytes in the normally pigmented epidermis of patients with vitiligo","volume":"79","author":"Moellmann G","year":"1982","journal-title":"J Invest Dermatol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jaad.2006.08.017","article-title":"High-potency steroid use in children with vitiligo: a retrospective study","volume":"56","author":"Kwinter J","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1517\/14656560903357509","article-title":"Vitiligo therapy","volume":"10","author":"Lotti T","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"ref23","first-page":"1532","article-title":"Nonsurgical repigmentation therapies in vitiligo. Meta-analysis of the literature","volume":"134","author":"Njoo MD","year":"1998","journal-title":"Arch Dermatol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1755-148X.2008.00528.x","article-title":"Update on skin repigmentation therapies in vitiligo","volume":"22","author":"Falabella R","year":"2009","journal-title":"Pigment Cell Melanoma Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2165\/00003495-200565040-00002","article-title":"New treatment modalities for vitiligo: focus on topical immunomodulators","volume":"65","author":"Kostovic K","year":"2005","journal-title":"Drugs"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1346-8138.2010.01067.x","article-title":"Effectiveness of 0.1% topical tacrolimus in adult and children patients with vitiligo","volume":"38","author":"Udompataikul M","year":"2011","journal-title":"J Dermatol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/archderm.139.5.581","article-title":"A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo","volume":"139","author":"Lepe V","year":"2003","journal-title":"Arch Dermatol"},{"key":"ref28","first-page":"88","article-title":"Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligo","volume":"15","author":"Coskun B","year":"2005","journal-title":"Eur J Dermatol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1525-1470.2009.00914.x","article-title":"Combination of 308-nm excimer laser with topical pimecrolimus for the treatment of childhood vitiligo","volume":"26","author":"Hui-Lan Y","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.0736-8046.2004.21418.x","article-title":"Calcipotriene and corticosteroid combination therapy for vitiligo","volume":"21","author":"Travis LB","year":"2004","journal-title":"Pediatr Dermatol"},{"key":"ref31","first-page":"256","article-title":"Once-daily application of calcipotriene 0.005%-betamethasone dipropionate 0.064% ointment for repigmentation of facial vitiligo","volume":"88","author":"Newman MD","year":"2011","journal-title":"Cutis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1046\/j.1365-4362.1999.00623.x","article-title":"The efficacy of low-dose oral corticosteroids in the treatment of vitiligo patients","volume":"38","author":"Kim SM","year":"1999","journal-title":"Int J Dermatol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1365-4362.1993.tb02754.x","article-title":"Oral mini-pulse therapy with betamethasone in vitiligo patients having extensive or fast-spreading disease","volume":"32","author":"Pasricha JS1","year":"1993","journal-title":"Int J Dermatol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1067\/mjd.2001.113475","article-title":"Oral dexamethasone pulse treatment for vitiligo","volume":"44","author":"Radakovic-Fijan S","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1600-0781.2011.00606.x","article-title":"Photo(chemo)therapy for vitiligo","volume":"27","author":"Pacifico A","year":"2011","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1001\/archderm.1997.03890480045006","article-title":"Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A","volume":"133","author":"Westerhof W","year":"1997","journal-title":"Arch Dermatol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1001\/archderm.143.5.578","article-title":"Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy","volume":"143","author":"Yones SS","year":"2007","journal-title":"Arch Dermatol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/2013.jamadermatol.386","article-title":"The efficacy of afamelanotide and narrowband UV-B phototherapy for repigmentation of vitiligo","volume":"149","author":"Grimes PE","year":"2013","journal-title":"JAMA Dermatol"},{"key":"ref39","first-page":"493","article-title":"Vitiligo: a comprehensive overview Part II: treatment options and approach to treatment","volume":"65","author":"Felsten LM","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3346\/jkms.2005.20.2.273","article-title":"Short-term effects of 308-nm xenon-chloride excimer laser and narrow-band ultraviolet B in the treatment of vitiligo: a comparative study","volume":"20","author":"Hong SB","year":"2005","journal-title":"J Korean Med Sci"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1468-3083.2007.02151.x","article-title":"Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo--a multicentre controlled study","volume":"21","author":"Casacci M1","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1365-2133.2010.09778.x","article-title":"308-nm excimer lamp vs. 308-nm excimer laser for treating vitiligo: a randomized study","volume":"163","author":"Le Duff F","year":"2010","journal-title":"Br J Dermatol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/phpp.12015","article-title":"Comparison of the 308-nm excimer laser with the 308-nm excimer lamp in the treatment of vitiligo--a randomized bilateral comparison study","volume":"29","author":"Shi Q","year":"2013","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1365-2133.2012.11008.x","article-title":"A review of monochromatic excimer light in vitiligo","volume":"167","author":"Park KK","year":"2012","journal-title":"Br J Dermatol"},{"key":"ref45","first-page":"1543","article-title":"A systematic review of autologous transplantation methods in vitiligo","volume":"134","author":"Njoo MD","year":"1998","journal-title":"Arch Dermatol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1524-4725.2011.02234.x","article-title":"Advanced treatment modalities for vitiligo","volume":"38","author":"Patel NS","year":"2012","journal-title":"Dermatol Surg"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1365-2133.2009.09367.x","article-title":"Long-term results of 2-mm punch grafting in patients with vitiligo vulgaris and segmental vitiligo: effect of disease activity","volume":"161","author":"Fongers A","year":"2009","journal-title":"Br J Dermatol"},{"key":"ref48","first-page":"S37","article-title":"Standard guidelines of care for vitiligo surgery","volume":"74","author":"Parsad D","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2133.2012.11197.x","article-title":"Guidelines for the management of vitiligo: the European Dermatology Forum consensus","volume":"168","author":"Taieb A","year":"2013","journal-title":"Br J Dermatol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1046\/j.1468-3083.2003.00718.x","article-title":"Surgical treatment of vitiligo: why, when and how","volume":"17","author":"Falabella R","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-4632.2005.02697.x","article-title":"Repigmentation of vitiligo with punch grafting and narrow-band UV-B (311 nm)--a prospective study","volume":"45","author":"Lahiri K","year":"2006","journal-title":"Int J Dermatol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1590\/S0365-05962012000500002","article-title":"Action of topical mometasone on the pigmented halos of micrografting in patients with vitiligo","volume":"87","author":"Saldanha KD","year":"2012","journal-title":"An Bras Dermatol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1524-4725.1995.tb00176.x","article-title":"Vitiligo: repigmentation with dermabrasion and thin splitthickness skin graft","volume":"21","author":"Agrawal K","year":"1995","journal-title":"Dermatol Surg"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1111\/bjd.12007","article-title":"Comparison between autologous noncultured epidermal cell suspension and suction blister epidermal grafting in stable vitiligo: a randomized study","volume":"167","author":"Budania A","year":"2012","journal-title":"Br J Dermatol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3727\/096368910X491798","article-title":"Transplantation of cultured autologous melanocytes: hope or danger?","volume":"19","author":"Czajkowski R","year":"2010","journal-title":"Cell Transplant"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abd\/v89n5\/0365-0596-abd-89-05-0784.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T15:00:42Z","timestamp":1747666842000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0365-05962014000500784&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0365-05962014000500784"],"URL":"https:\/\/doi.org\/10.1590\/abd1806-4841.20142717","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}